AzurRx BioPharma, Inc.

AzurRx BioPharma, Inc.verified

AZRX

Price:

$3.45

Market Cap:

$3.43M

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company is headquartered in Brooklyn, New York and currently employs 12 full-time employees. The firm is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The firm's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine...[Read more]

Industry

Biotechnology

IPO Date

2016-10-11

Stock Exchange

NASDAQ

Ticker

AZRX

The Enterprise Value as of November 2025 (TTM) for AzurRx BioPharma, Inc. (AZRX) is 1.75M

According to AzurRx BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.75M. This represents a change of -86.08% compared to the average of 12.58M of the last 4 quarters.

AzurRx BioPharma, Inc. (AZRX) Historical Enterprise Value (quarterly & annually)

How has AZRX Enterprise Value performed in the past?

The mean historical Enterprise Value of AzurRx BioPharma, Inc. over the last ten years is 35.02M. The current 1.75M Enterprise Value has changed 400.04% with respect to the historical average. Over the past ten years (40 quarters), AZRX's Enterprise Value was at its highest in in the March 2021 quarter at 62.55M. The Enterprise Value was at its lowest in in the December 2020 quarter at -6062141.00.

Quarterly (TTM)
Annual

Average

35.02M

Median

38.50M

Minimum

11.83M

Maximum

53.96M

AzurRx BioPharma, Inc. (AZRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AzurRx BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 116.88%

Maximum Annual Enterprise Value = 53.96M

Minimum Annual Increase = -77.97%

Minimum Annual Enterprise Value = 11.83M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202411.83M-77.97%
202053.68M116.88%
201924.75M38.88%
201817.82M-53.71%
201738.50M-13.68%
201644.60M-17.34%

AzurRx BioPharma, Inc. (AZRX) Average Enterprise Value

How has AZRX Enterprise Value performed in the past?

The current Enterprise Value of AzurRx BioPharma, Inc. (AZRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

30.09M

5-year avg

29.32M

10-year avg

35.02M

AzurRx BioPharma, Inc. (AZRX) Enterprise Value vs. Peers

How is AZRX’s Enterprise Value compared to its peers?

AzurRx BioPharma, Inc.’s Enterprise Value is greater than Lisata Therapeutics, Inc. (-1137763.00), greater than Onconetix, Inc. (998.20K), less than Unity Biotechnology, Inc. (18.05M), less than Atreca, Inc. (36.62M), greater than Idera Pharmaceuticals, Inc. (-11484000.00), greater than VivoSim Labs, Inc. (-2156449.00), less than RVL Pharmaceuticals plc (16.09M), less than Gritstone bio, Inc. (43.29M), greater than Altamira Therapeutics Ltd. (393.71K), less than Q32 Bio Inc. (5.13M),

Build a custom stock screener for AzurRx BioPharma, Inc. (AZRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AzurRx BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AzurRx BioPharma, Inc. (AZRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AzurRx BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is AzurRx BioPharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for AzurRx BioPharma, Inc. (AZRX)?

What is the 3-year average Enterprise Value for AzurRx BioPharma, Inc. (AZRX)?

What is the 5-year average Enterprise Value for AzurRx BioPharma, Inc. (AZRX)?

How does the current Enterprise Value for AzurRx BioPharma, Inc. (AZRX) compare to its historical average?